Biotechnology
Cancer Prevention
Health
Exact Sciences
$117.209876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$117.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$1.08 (0.93%) Today
+$0.07 (0.06%) As of 5:58 PM EDT after-hours
Why Robinhood?
You can buy or sell Exact Sciences and other stocks, options, ETFs, and crypto commission-free!
About EXAS
Exact Sciences Corporation Common Stock, also called Exact Sciences, is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. Read More The company was founded on February 10, 1995 and is headquartered in Madison, WI.
Employees
1,977
Headquarters
Madison, Wisconsin
Founded
1995
Market Cap
14.98B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
1.08M
High Today
$117.78
Low Today
$114.84
Open Price
$116.29
Volume
1.01M
52 Week High
$121.98
52 Week Low
$47.78
Collections
Biotechnology
Cancer Prevention
Health
Technology
Price Paid on Robinhood
106% Higher
Right Now
52 Week Low
$44.85
Average Price Paid
$56.96
52 Week High
$99.52
Analyst Ratings
85%
of 13 ratings
Buy
85%
Hold
15%
Sell
0%
EXAS Earnings
-$0.65
-$0.49
-$0.34
-$0.18
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Available Jul 30, After Hours